Levagen from Gencor earns ANVISA Novel Food Certification
Agencia Nacional de Vigilancia Sanitaria (ANVISA), Brazil’s national health surveillance agency, certified Gencor’s (Irvine, CA) Levagen as a novel food.
Photo © iStockphoto.com/volk65
Agencia Nacional de Vigilancia Sanitaria (ANVISA), Brazil’s national health surveillance agency, certified Gencor’s (Irvine, CA) Levagen as a novel food. Within Brazil, this certification allows Gencor to market and sell Levagen as “ANVISA certified.”
“The ANVISA Novel Food certification opens the Brazilian market for Levagen and strengthens Gencor’s position as an innovator of ingredients that consumers can trust,” said R.V. Venkatesh, Gencor’s managing director, in a press release. “We are very happy to have achieved the certification and will continue to provide ingredients that are well-studied and convey benefits that consumers value.”
Levagen is a clinically studied form of palmitolethanolamide (PEA), which is a fatty acid amide that increases levels of anandamide, an endocannabinoid that regulates pain and sleep receptors.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
